He believes CAR T-cell therapy could become the first, rather than the last line of defence in treating blood cancers. "The treatment of blood cancers is often 10 years ahead of the treatment of solid cancers, mainly because solid cancers are more complex. "It takes a lot of people to make a cancer therapy, get it to the patient, and look after that patient. '…"How CAR T-Cell therapy worksPule’s immunotherapy clinical trials focus on using an immune cell called a T-cell to attack cancer. With CAR-T cell therapy, Pule and his team take T-cells from a patient’s blood and reprogramme them to recognise the cancer cells.

Source: Irish Independent October 26, 2019 01:37 UTC